Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Kidney Cancer Article
This is a selection made from among articles on Drug Treatment Kidney Cancer. For a permanent link to this article, or to bookmark it for future reading, click here.
New Drug Rehab Model Used in Second Chance Program in Albuquerque
from:by Kris Nickerson
A new drug rehabilitation program that uses long-term nutritional and sauna-based detoxification – with no alternative drugs – is achieving high success statistics in a prison setting. Run by Rick Pendery, the national executive director of the Second Chance Centers, and Joy Westrum, the president of the Second Chance Program (www.secondchanceprogram.net), the program has been running for several months in a secure setting in Albuquerque, NM.Westrum explains that the purpose of the program is to “provide secure, long-term rehabilitation for substance abusers in the criminal justice system, and then to transition them back into society so they can lead a stable life free of crime and drugs. The program includes the administration of vitamins and mineral supplements twice a day, drills designed to extrovert the inmate’s attention, and physical techniques designed to decrease the physical trauma of withdrawal that are administered by other inmates. The entire process is supervised by a staff member trained in the process.”This long-term detoxification process has been used throughout the world, not only to assist people in getting off drugs, but also to remove chemicals and other toxins from the system. For example, it was used by the New York Fire Department and others who worked at Ground Zero after the disaster of 9/11.“When the person has completed the long-term detox, the metabolic residuals from years of substance abuse are eliminated from the body. We have found that the detox measurably decreases the craving to take more drugs,” Pendery explains. “The also appear more healthy, as witnessed by physical indicators, such as improved skin tone and clear eyes, as well as social indicators like higher activity levels, better communication skills, and so forth.”Those on the program also engage in what are called Therapeutic Training Routines, which are known to increase the inmate’s attention and awareness of his present environment, raise his ability to comfortably confront others and examine his own life, and raise his ability to give and receive communication. In the process, the inmate’s level of responsibility, ability to gain control over his emotions, ability to control others, and willingness to be controlled also increase. “These routines consist of actual communication drills that were developed by L. Ron Hubbard, the founder of a newly recognized religion called Scientology,” explains Pendery. “Second Chance is a secular program that uses protocol-based research from Mr. Hubbard, but Second Chance is non-religious by nature and is not part of the Church of Scientology. Developing better communication skills, eliminating toxins stored in the body, and learning tools that more effectively help someone learn and apply what they learn are examples of some of these protocols. Our center provides Sunday Catholic and Protestant services, and practices an official policy of respecting the religious beliefs of others. The inmates here are encouraged to pray, read the Bible, meditate, or take part in any religious activity.”Concludes Pendery, “The results of this part of our program really pull the individual out of his ‘drug life.’ The remaining steps help stabilize him so he can successful reintegrate into society.”Kent McGregor, previously the Director of Substance Abuse for New Mexico and later a Commission on Accreditation of Rehabilitation Facilities Certifier, has acted as a consultant for the Second Chance Program. He outlined how the various parts of the Second Chance Program fall within what is considered to be the best practice in substance abuse treatment, saying, “The Second Chance program uses a holistic approach of exercise combined with the use of nutrients to replace metabolic deficiencies. They use a sauna/nutritional detoxification therapy that reduces the burden of toxic body metabolites. They additionally use motivational interviews, contingency management, community reinforcement therapy all combined into a successful matrix model in a social detox therapeutic community environment.Information about the Second Chance Program can be found at www.secondchanceprogram.net.
Kris Nickerson is the Editor-in-Chief of Press Direct International (www.pressdirectinternational.org), a global information website that provides reliable information tailored to professionals in financial, media, and corporate markets. His thorough knowledge of industries ranging from health care and travel to real estate and financial investing enables him to quickly grasp the nuances of emerging markets and technologies.
Drug Treatment Kidney Cancer Specific links
Drug Treatment Kidney Cancer News
Aveo kidney cancer drug more tolerated than Nexavar
(Reuters) - Patients taking a kidney cancer drug being developed by Aveo Pharmaceuticals Inc were half as likely to need a break from the medication due to side effects than those on the widely used medicine Nexavar, according to data released on Wednesday. There were also significantly fewer patients taking Aveo's tivozanib who required a dose reduction than those on Nexavar. ...
Read more...Pfizer says EU recommends approval of Inlyta
Pfizer Inc. said Friday that European Union regulators are recommending approval for its kidney cancer drug Inlyta.A European Union advisory committee recommended that Inlyta be approved as a treatment ...
Read more...Onyx rises on analyst view of blood cancer drug
Onyx Pharmaceuticals Inc. shares rose Thursday after a Bernstein Research analyst started covering the stock with an "Outperform" rating, saying he thinks the company's blood cancer drug candidate will reach $1 billion in annual sales by 2016.
Read more...Bayer, Onyx cancer drug fails in late-stage study
A cancer treatment from Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals Inc. failed to meet its main, late-stage study goal of improving overall survival in patients with advanced cases of lung cancer.
Read more...Indian drug giant Cipla slashes cancer drug prices
Indian generic drug giant Cipla said Friday it had slashed by up to 76 percent prices of three anti-cancer medicines in what it called a "humanitarian" move and promised to cut the costs of more products.
Read more...Press Release
Pfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of advanced kidney cancer, after failure of prior treatment with sunitinib or a cytokine.
Read more...Aveo sees positive safety data for kidney cancer drug
Aveo Oncology (NASDAQ:AVEO) of Cambridge and partner Astellas Pharma Inc. (TSE:4503) of Tokyo revealed more data from the TIVO-1 Phase 3 clinical trial of tivozanib, their drug candidate for renal cell carcinoma, including positive tolerability data.
Read more...Pfizer cancer drug gets nod
Full content sent to and hosted by Yahoo!General NewsHealth & MedicineIndustry SnapshotNew Issue AmericaReal EstateTop 10Feature StoryInvestor's Corner
Read more...Pfizer’s Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line ...
Pfizer announced today that the Committee for Human Medicinal Products of the European Medicines Agency has adopted a positive opinion regarding the marketing authoriz
Read more...Novartis Drug Afinitor® Approved By FDA As First Medication To Treat Patients With Non-Cancerous Kidney Tumors ...
Novartis Pharmaceuticals Corporation ("Novartis") announced today that the US Food and Drug Administration (FDA) approved Afinitor® (everolimus) tablets* for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery(2).
Read more...